Companies: โ€”ยทtotal market cap: โ€”
$ USD
companiesbycap
Menu
Global rankingSuperinvestors
Countries
๐Ÿ‡บ๐Ÿ‡ธUnited States๐Ÿ‡จ๐Ÿ‡ฆCanada๐Ÿ‡ฉ๐Ÿ‡ชGermany๐Ÿ‡ซ๐Ÿ‡ทFrance๐Ÿ‡ฌ๐Ÿ‡งUnited Kingdom๐Ÿ‡จ๐Ÿ‡ญSwitzerland๐Ÿ‡ฎ๐Ÿ‡ณIndia๐Ÿ‡ฏ๐Ÿ‡ตJapan
Categories
๐Ÿ’ปTechnology๐ŸฆFinancials๐Ÿ’ŠHealthcare๐Ÿ›๏ธConsumer Cyclical๐Ÿ“กCommunication๐ŸญIndustrials๐Ÿ›’Consumer DefensiveโšกEnergy
TYRA
Tyra Biosciences, Inc. TYRA
$28.30
โ–ฒ +5.55% 24H
5.2613.8522.4431.0239.612021-092022-112024-012025-042026-06

About

Tyra Biosciences Inc. is a biotechnology company focused on developing precision therapies to address drug resistance in cancer treatments. Founded with the mission to advance cancer therapy through targeted innovation, Tyra Biosciences specializes in creating small-molecule inhibitors that can overcome the limitationsโ€ฆ

SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees87
TickerTYRA

Statistics

Market Cap$1.68B
Revenue (TTM)$0
Net Income-$119.9M
Net Marginโ€”
EPS$-2.01
P/E-12.72
P/Sโ€”
P/B5.27
EV/EBITDA-7.96
ROE-36.9%
Dividend Yieldโ€”
Price$28.30

Data: Twelve Data ยท Revenue = mcap / P/S

Tyra Biosciences, Inc. (TYRA) โ€” Market Cap, Revenue, Net Income, P/E | companiesbycap